E. L. Pearce, M. C. Poffenberger, C. Chang, and R. G. Jones, Fueling immunity: insights into metabolism and lymphocyte function, Science, vol.342, p.1242454, 2013.

M. Laplante and D. M. Sabatini, mTOR signaling at a glance, J. Cell Sci, vol.122, pp.3589-3594, 2009.

S. Colombetti, V. Basso, D. L. Mueller, and A. Mondino, Prolonged TCR/ CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin, J. Immunol, vol.176, pp.2730-2738, 2006.

Y. Zheng, S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole et al., A role for mammalian target of rapamycin in regulating T cell activation versus anergy, J. Immunol, vol.178, pp.2163-2170, 2007.

Y. Zheng, G. M. Delgoffe, C. F. Meyer, W. Chan, and J. D. Powell, Anergic T cells are metabolically anergic, J. Immunol, vol.183, pp.6095-6101, 2009.

S. Haxhinasto, D. Mathis, and C. Benoist, The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells, J. Exp. Med, vol.205, pp.565-574, 2008.

S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu et al., T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR, Proc. Natl. Acad. Sci. USA, vol.105, pp.7797-7802, 2008.

G. M. Delgoffe, T. P. Kole, Y. Zheng, P. E. Zarek, K. L. Matthews et al., The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment, Immunity, vol.30, pp.832-844, 2009.

G. M. Delgoffe, K. N. Pollizzi, A. T. Waickman, E. Heikamp, D. J. Meyers et al., The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2, Nat. Immunol, vol.12, pp.295-303, 2011.

C. Liu, N. M. Chapman, P. W. Karmaus, H. Zeng, and H. Chi, mTOR and metabolic regulation of conventional and regulatory T cells, J. Leukoc. Biol, vol.97, pp.837-847, 2015.

R. D. Michalek, V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. Maciver et al., Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets, J. Immunol, vol.186, pp.3299-3303, 2011.

S. Basu, B. Hubbard, and E. M. Shevach, Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells, J. Leukoc. Biol, vol.97, pp.279-283, 2015.

V. A. Gerriets, R. J. Kishton, M. O. Johnson, S. Cohen, P. J. Siska et al., Foxp3 and toll-like receptor signaling balance T reg cell anabolic metabolism for suppression, Nat. Immunol, vol.17, pp.1459-1466, 2016.

A. Angelin, L. Gil-de-gómez, S. Dahiya, J. Jiao, L. Guo et al., Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments, Cell Metab, vol.25, pp.1282-1293, 2017.

V. De-rosa, M. Galgani, A. Porcellini, A. Colamatteo, M. Santopaolo et al., Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants, Nat. Immunol, vol.16, pp.1174-1184, 2015.

C. Procaccini, F. Carbone, D. Di-silvestre, F. Brambilla, V. Rosa et al., The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements, Immunity, vol.44, pp.406-421, 2016.

H. Zeng, K. Yang, C. Cloer, G. Neale, P. Vogel et al., 2013. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function, Nature, vol.499, pp.485-490

N. M. Chapman, H. Zeng, T. M. Nguyen, Y. Wang, P. Vogel et al., mTOR coordinates transcriptional programs and mitochondrial metabolism of activated T reg subsets to protect tissue homeostasis, Nat. Commun, vol.9, p.2095, 2018.

B. Priyadharshini, M. Loschi, R. H. Newton, J. Zhang, K. K. Finn et al., Cutting edge: TGF-b and phosphatidylinositol 3-kinase signals modulate distinct metabolism of regulatory T cell subsets, J. Immunol, vol.201, pp.2215-2219, 2018.

I. Sun, M. Oh, L. Zhao, C. H. Patel, M. L. Arwood et al., mTOR complex 1 signaling regulates the generation and function of central and effector Foxp3 + regulatory T cells, J. Immunol, vol.201, pp.481-492, 2018.

A. Lainé, B. Martin, M. Luka, L. Mir, C. Auffray et al., Foxo1 is a T cell-intrinsic inhibitor of the RORgt-Th17 program, J. Immunol, vol.195, pp.1791-1803, 2015.

G. M. Mackay, L. Zheng, N. J. Van-den-broek, and E. Gottlieb, Analysis of cell metabolism using LC-MS and isotope tracers, Methods Enzymol, vol.561, pp.171-196, 2015.

V. Risson, L. Mazelin, M. Roceri, H. Sanchez, V. Moncollin et al., Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy, J. Cell Biol, vol.187, pp.859-874, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02126916

Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli et al., Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces, Immunity, vol.28, pp.546-558, 2008.

T. R. Mempel and F. Marangoni, Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response, Immunol. Rev, vol.289, pp.129-141, 2019.

D. Finlay and D. A. Cantrell, Metabolism, migration and memory in cytotoxic T cells, Nat. Rev. Immunol, vol.11, pp.109-117, 2011.

S. K. Pabbisetty, W. Rabacal, E. J. Volanakis, V. V. Parekh, D. Olivares-villagómez et al., Peripheral tolerance can be modified by altering KLF2-regulated Treg migration, Proc. Natl. Acad. Sci. USA, vol.113, pp.4662-4670, 2016.

T. J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat. Med, vol.10, pp.942-949, 2004.

B. D. Sather, P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot et al., Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease, J. Exp. Med, vol.204, pp.1335-1347, 2007.

X. Zhou, S. L. Bailey-bucktrout, L. T. Jeker, C. Penaranda, M. Martínez-llordella et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, Nat. Immunol, vol.10, pp.1000-1007, 2009.

J. H. Duarte, S. Zelenay, M. Bergman, A. C. Martins, and J. Demengeot, Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions, Eur. J. Immunol, vol.39, pp.948-955, 2009.

L. Xu, A. Kitani, I. Fuss, and W. Strober, Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta, J. Immunol, vol.178, pp.6725-6729, 2007.

X. O. Yang, R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs, Immunity, vol.29, pp.44-56, 2008.

X. Zhou, S. Bailey-bucktrout, L. T. Jeker, and J. A. Bluestone, Plasticity of CD4(+) FoxP3(+) T cells, Curr. Opin. Immunol, vol.21, pp.281-285, 2009.

Y. Tone, K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene et al., Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer, Nat. Immunol, vol.9, pp.194-202, 2008.

W. Ouyang, O. Beckett, R. A. Flavell, and M. O. Li, An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance, Immunity, vol.30, pp.358-371, 2009.

C. T. Luo, W. Liao, S. Dadi, A. Toure, and M. O. Li, Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity, Nature, vol.529, pp.532-536, 2016.

M. Kishore, K. C. Cheung, H. Fu, F. Bonacina, G. Wang et al., Regulatory T cell migration is dependent on glucokinase-mediated glycolysis, Immunity, vol.48, pp.875-889, 2017.

D. Klysz, X. Tai, P. A. Robert, M. Craveiro, G. Cretenet et al., Glutamine-dependent a-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation, Sci. Signal, vol.8, p.97, 2015.

T. Xu, K. M. Stewart, X. Wang, K. Liu, M. Xie et al., Metabolic control of T H 17 and induced T reg cell balance by an epigenetic mechanism, Nature, vol.548, pp.228-233, 2017.

L. Charbonnier, Y. Cui, E. Stephen-victor, H. Harb, D. Lopez et al., Functional reprogramming of regulatory T cells in the absence of Foxp3, Nat. Immunol, vol.20, pp.1208-1219, 2019.